Elite Pharmaceuticals Inc (ELTP) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2026, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Elite Pharmaceuticals Inc   (ELTP)
 

Elite Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Elite Pharmaceuticals Inc inventory turnover ratio, the Elite Pharmaceuticals Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 3.95 in the first quarter 2026, a new company high. Average inventory processing period, for the Elite Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 92 days, compare to 95 days, in the Mar 31 2026 quarter.

Within Healthcare sector 108 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1128, from total ranking in the fourth quarter 2026 at 1154.

ELTP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Elite Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELTP Inventory Turnover Ratio (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Inventory Growth 25.02 % 30.91 % 25.6 % 28.24 % 39.95 %
Y / Y Cost of Sales Growth 57.06 % 33.17 % 125 % 120 % 20 %
Inventory Turnover Ratio (TTM) 3.95 3.84 3.83 3.42 2.87
ELTP's Total Ranking # 1128 # 1154 # 333 # 1019 # 1051
Average inventory processing period 92 95 95 107 127
Seq. Inventory Growth 13.83 % 30.91 % -10.59 % -6.16 % 19.19 %
Seq. Cost of Sales Growth -5.65 % 10.98 % -18.18 % 83.33 % -20 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 22
Healthcare Sector # 109
Overall Market # 1128

Inventory Turnover Ratio Statistics
High Average Low
3.95 1.97 0.55
(Jun 30 2026)   (Dec 31 2017)



ELTP Company Profile >> Back to ELTP Efficiency Comparisons >> Compare ELTP Inventory Turnover Ratio to its Competitors

Financial Statements
Elite Pharmaceuticals Inc 's Inventories $ 24 Millions Visit ELTP's Balance sheet
Elite Pharmaceuticals Inc 's Cost of Revenues TTM $ 79 Millions Visit ELTP's Income Statement
What are ELTP's Sales? Visit ELTP's Sales by Segment

Other Inventory Turnover Ratios
Elite Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ELTP's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ELTP's Competitors
Inventory Turnover Ratio for ELTP's Suppliers
Inventory Turnover Ratio for ELTP's Customers

You may also want to know
ELTP's Sales Growth Rates ELTP's Pe Price to earnings ratio ELTP's Receivables Turnover Ratio ELTP's Stock Quote
ELTP's Net Income Growth Rates ELTP's Ps Price to Sales ratio ELTP's Sales per Employee ELTP's Asset Turnover Ratio
ELTP's Net Margin ELTP's Pb Price to Book ratio ELTP's Financial Strength Ratios ELTP's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions

Date modified: 2026-09-01T19:54:32+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.